Healthcare stocks on the Nigerian Exchange
Pharma manufacturers and hospitals — a defensive, under-followed corner of the NGX.
All Healthcare stocks on the NGX
| Ticker | Price | Change | Volume | Market Cap |
|---|---|---|---|---|
| MECURE MeCure Industries Plc |
₦61.50 | +0.00% | 41,645 | ₦246.00B |
| FIDSON Fidson Healthcare Plc |
₦100.00 | +5.43% | 956,932 | ₦229.50B |
| MAYBAKER May & Baker Nigeria Plc |
₦38.00 | -9.42% | 2,301,172 | ₦65.56B |
| NEIMETH Neimeth International Pharmaceutical |
₦10.20 | -2.39% | 4,002,913 | ₦43.59B |
| MORISON Morison Industries Plc |
₦11.80 | +0.00% | 129,146 | ₦14.82B |
| EKOCORP Eko Corporation Plc |
₦5.80 | +0.00% | — | ₦2.89B |
| PHARMDEKO Pharma-Deko Plc |
₦1.83 | +0.00% | — | ₦396.8M |
About Healthcare on the NGX
Healthcare on the NGX is built almost entirely around pharmaceutical manufacturers — Fidson Healthcare, May & Baker Nigeria, Mecure Industries, Neimeth International Pharmaceuticals, Glaxo SmithKline Consumer Nigeria (delisted but historically here), Morison Industries and Pharmadeko — plus Ekocorp, the listed hospital operator.
The sector is small in market cap but structurally interesting. Nigeria spends a fraction of GDP on healthcare relative to peers, so the long-run demand curve is steep. The current investment thesis is around local manufacturing scale-up: government incentives, recapitalisation of pharma plants, and the push to substitute imported drugs after the 2023 exit of GlaxoSmithKline. Healthcare names trade at lower multiples than consumer goods and are often forgotten in market rallies — they reward patient, valuation-disciplined buyers.